Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)

Status:
Completed

Trial end date:
2014-04-01

Target enrollment:

Participant gender:

The primary objective of this study is to evaluate the analgesic efficacy of 2 dose levels of V116517 versus placebo.

Phase 2

Purdue Pharma LP

Analgesics
Pregabalin